Juárez-Hernández E, Chávez-Tapia NC, Brizuela-Alcántara DC, Uribe M, Ramos-Ostos MH, Nuño-Lámbarri N

Idioma: Ingles.
Referencias bibliográficas: 33
Paginas: 577-584
Archivo PDF: 224.58 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Nuño-Lámbarri N, Baulies-Domenech A, Monte MJ, G. Marin JJ, Rosales-Cruz P, Souza V, Miranda RU, et al. Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice. Oxidative Medicine and Cellular Longevity 2016; 2016.

2. Wang R, Wang X, Zhuang L. Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease. Ann Hepatol 2016; 15: 190-9.

3. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.

4. Liu W, Baker SS, Baker RD, Nowak NJ, Zhu L. Up-regulation of hemoglobin expression by oxidative stress in hepato cytes and its implication in nonalcoholic steatohepatitis. PloS one 2011; 6.

5. Yu C, Xu C, Xu L, Yu J, Miao M, Li Y. Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease. J Hepatology 2012; 56: 241-7.

6. Brodosi L, Marchignoli F, Petroni ML, Marchesini G. NASH: A glance at the landscape of pharmacological treatment. Ann Hepatol 2016; 15: 673-81.

7. Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clinical chemistry 2007; 53: 686-92.

8. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clinics in liver disease 2007; 11: 1-16.

9. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Seminars in liver disease 2008; 28: 386-95.

10. Bahl M, Qayyum A, Westphalen AC, Noworolski SM, Chu PW, Ferrell L, Tien PC, et al. Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. Radiology 2008; 249: 160-6.

11. Ascenzi P, Bocedi A, Visca P, Altruda F, Tolosano E, Beringhelli T, Fasano M. Hemoglobin and heme scavenging. IUBMB life 2005; 57: 749-59.

12. Soon Yew Tang IKMC, Pei Ern Ng, Aina Hoi, Andrew M. Jenner. Heme Consumption Reduces Hepatic Triglyceride and Fatty Acid Accumulation in a Rat Model of NAFLD Fed Westernized Diet. ISRN Oxidative Medicine 2014; 2014.

13. Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannage-Yared MH, Bedossa P, et al. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery. Gut 2009; 58: 825-32.

14. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.

15. Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-62.

16. Li X, Wu Z, Wang Y, Mei Q, Fu X, Han W. Characterization of adult alpha- and beta-globin elevated by hydrogen peroxide in cervical cancer cells that play a cytoprotective role against oxidative insults. PloS one 2013; 8: e54342.

17. Akyuz U, Yesil A, Yilmaz Y. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels. Scandinavian J Gastroenterol 2015; 50: 341-6.

18. Tanoglu A, Kara M. Nonalcoholic fatty liver disease-related cardiovascular risk: Is there an association with blood hemoglobin levels? European J Gastroenterol & Hepatol 2015; 27: 1126-9.

19. Xu L, Xu CF, Yu CH, Miao M, Li YM. Haemoglobin and non-alcoholic fatty liver disease: further evidence from a population- based study. Gut 2009; 58: 1706-7.

20. Bai CH, Wu MS, Owaga E, Cheng SY, Pan WH, Chang JS. Relationship between hemoglobin levels and risk for suspected non-alcoholic fatty liver in Taiwanese adults. Chin J Physiol 2014; 57: 286-94.

21. Chung GE, Yim JY, Kim D, Kwak MS, Yang JI, Chung SJ, Yang SY, et al. Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease. Dig Liver Dis 2017; 49: 57-62.

22. Giorgio V, Mosca A, Alterio A, Alisi A, Grieco A, Nobili V, Miele L. Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr 2017; 65: 150-5.

23. Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, Hultcrantz R, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS medicine 2014; 11: e1001680.

24. Orlic L, Mikolasevic I, Bagic Z, Racki S, Stimac D, Milic S. Chronic kidney disease and nonalcoholic Fatty liver diseaseis there a link? Gastroenterology Research and Practice 2014; 2014: 847539.

25. Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clinical journal of the American Society of Nephrology: CJASN 2010; 5: 2166-71.

26. Xia MF, Lin HD, Li XM, Yan HM, Bian H, Chang XX, He WY, et al. Renal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middleaged and elderly Chinese population. Clinical and Experimental Pharmacology & Physiology 2012; 39: 930-7.

27. Tian J, Zhong R, Liu C, Tang Y, Gong J, Chang J, Lou J, et al. Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study. Scientific reports 2016; 6: 31006.

28. Brunyanszki A, Erdelyi K, Szczesny B, Olah G, Salomao R, Herndon DN, Szabo C. Upregulation and mitochondrial sequestration of hemoglobins occurs in circulating leukocytes during critical illness, conferring a cytoprotective phenotype. Molecular medicine 2015.

29. Yilmaz Y. NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression? Seminars in liver disease 2012; 32: 14-21.

30. Widmer CC, Pereira CP, Gehrig P, Vallelian F, Schoedon G, Buehler PW, Schaer DJ. Hemoglobin can attenuate hydrogen peroxide-induced oxidative stress by acting as an antioxidative peroxidase. Antioxidants & redox signaling 2010; 12: 185-98.

31. Handa P, Vemulakonda AL, Maliken BD, Morgan-Stevenson V, Nelson JE, Dhillon BK, Hennessey KA, et al. Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis. Ann Hepatol 2017; 16: 77-85.

32. Soon Yew Tang IKMC, Pei Ern Ng, Aina Hoi, Andrew M. Jenner. Heme Consumption Reduces Hepatic Triglyceride and Fatty Acid Accumulation in a Rat Model of NAFLD Fed Westernized Diet. ISRN Oxidative Medicine 2014; 9 (2014).

33. Trojak A, Walus-Miarka M, Wozniakiewicz E, Malecki MT, Idzior-Walus B. Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2013; 19: 1167-72.